[go: up one dir, main page]

ECSP12011893A - COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY - Google Patents

COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY

Info

Publication number
ECSP12011893A
ECSP12011893A ECSP12011893A ECSP12011893A EC SP12011893 A ECSP12011893 A EC SP12011893A EC SP12011893 A ECSP12011893 A EC SP12011893A EC SP12011893 A ECSP12011893 A EC SP12011893A
Authority
EC
Ecuador
Prior art keywords
therapy
theobromine
drugs
combination
opiate
Prior art date
Application number
Other languages
Spanish (es)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of ECSP12011893A publication Critical patent/ECSP12011893A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un agente comprende teobromina y un opiato, para el uso simultáneo, secuencial o por separado en terapia. Preferentemente, la terapia es para la tos.An agent comprises theobromine and an opiate, for simultaneous, sequential or separate use in therapy. Preferably, the therapy is for cough.

ECSP12011893 2009-11-13 2012-05-11 COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY ECSP12011893A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0919893.8A GB0919893D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy
PCT/GB2010/051896 WO2011058374A1 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy

Publications (1)

Publication Number Publication Date
ECSP12011893A true ECSP12011893A (en) 2012-10-30

Family

ID=41509327

Family Applications (2)

Application Number Title Priority Date Filing Date
ECSP12011893 ECSP12011893A (en) 2009-11-13 2012-05-11 COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY
ECSP12011892 ECSP12011892A (en) 2009-11-13 2012-05-11 COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY

Family Applications After (1)

Application Number Title Priority Date Filing Date
ECSP12011892 ECSP12011892A (en) 2009-11-13 2012-05-11 COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY

Country Status (19)

Country Link
EP (1) EP2498776A1 (en)
JP (2) JP2013510842A (en)
CN (1) CN102740853B (en)
AU (1) AU2010317668C1 (en)
BR (1) BR112012011224A2 (en)
CA (1) CA2780704C (en)
CO (1) CO6551745A2 (en)
EC (2) ECSP12011893A (en)
GB (1) GB0919893D0 (en)
IL (1) IL219769A0 (en)
MX (1) MX2012005538A (en)
NZ (1) NZ599957A (en)
PE (1) PE20121472A1 (en)
PH (1) PH12012500955A1 (en)
RU (1) RU2587329C2 (en)
SG (1) SG10201407496SA (en)
UA (1) UA105940C2 (en)
WO (1) WO2011058374A1 (en)
ZA (1) ZA201204247B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2523588A (en) * 1987-10-08 1989-05-02 Andor Bilas Mixture of substances for stabilyzing metabolism
WO1995007103A1 (en) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
HUP9700654A2 (en) * 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
US6608073B1 (en) * 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
AU2002356962C1 (en) * 2001-12-12 2008-05-01 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
RU2362559C2 (en) * 2003-02-28 2009-07-27 ЙЭм БАЙОСАЙЕНСИЗ ИНК. System of opioids delivery
CN1593451A (en) * 2003-09-12 2005-03-16 杨喜鸿 Externally applied medicine for promoting male erection
WO2006064780A1 (en) * 2004-12-14 2006-06-22 Shionogi & Co., Ltd. Therapeutic agent for constipation
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (en) * 2006-07-25 2008-01-30 안국약품 주식회사 Cough Treatment Composition

Also Published As

Publication number Publication date
CA2780704A1 (en) 2011-05-19
JP2016041748A (en) 2016-03-31
CN102740853A (en) 2012-10-17
CO6551745A2 (en) 2012-10-31
UA105940C2 (en) 2014-07-10
PE20121472A1 (en) 2012-11-30
SG10201407496SA (en) 2015-02-27
AU2010317668B2 (en) 2015-01-22
WO2011058374A1 (en) 2011-05-19
ZA201204247B (en) 2013-02-27
AU2010317668C1 (en) 2016-02-11
IL219769A0 (en) 2012-07-31
EP2498776A1 (en) 2012-09-19
BR112012011224A2 (en) 2017-03-01
RU2012124063A (en) 2013-12-20
RU2587329C2 (en) 2016-06-20
NZ599957A (en) 2014-05-30
PH12012500955A1 (en) 2013-01-07
MX2012005538A (en) 2012-09-28
CN102740853B (en) 2015-04-08
JP2013510842A (en) 2013-03-28
AU2010317668A1 (en) 2012-06-07
ECSP12011892A (en) 2012-09-28
CA2780704C (en) 2018-07-17
GB0919893D0 (en) 2009-12-30

Similar Documents

Publication Publication Date Title
CL2009001099A1 (en) Use of a human interleukin-2 mutein for the treatment and / or prevention of an autoimmune disease.
CL2014002406A1 (en) Method for the treatment of refractory or resistant treatment depression comprising administering esketamine intravenously or intranasally alone or in combination with one or more antidepressants; pharmaceutical composition; and its use in the treatment of refractory or treatment resistant depression.
CL2012003026A1 (en) Pharmaceutical composition comprising pioglitazone and linagliptin; preparation procedure; Use in the treatment of type 2 diabetes or obesity.
CL2009000545A1 (en) Use of a c-met antagonist and a her antagonist for the treatment of cancer.
CL2011001811A1 (en) A method of treating a patient who has suffered an acute myocardial infarction that comprises the use of an antifibrotic agent.
CL2011001232A1 (en) Pharmaceutical combination comprising an antibody that specifically recognizes cd38 and at least cytarabine; and its use for cancer treatment
GT200800250A (en) ARILIMIDAZOLONAS AND ARILTRIAZOLONAS REPLACED AS INHIBITORS OF VASOPRESINE RECEPTORS
CL2012003281A1 (en) Use of specific sgc stimulating and / or activating compounds; pharmaceutical formulation comprising said compounds; kit comprising the compounds, and use for the prevention and / or treatment of systematic sclerosis.
CL2011000301A1 (en) Compounds derived from purine with immunomodulatory activity; pharmaceutical composition comprising them; and use of them in the treatment of allergic diseases, allergic rhinitis, asthma, infectious diseases and cancer.
CL2011001331A1 (en) Nalmefene Hydrochloride Dihydrate; methods for its preparation; pharmaceutical composition comprising it; and use for the treatment of alcoholism.
CL2013000098A1 (en) Pharmaceutical composition containing an activated and potentiated formulation of an antibody to the human cannabinoid receptor; methods of use
CL2012002887A1 (en) Pharmaceutical combination comprising compounds derived from substituted 2,3-dihydroimidazo [1,2-c] quinazoline, compounds derived from n- (2-arylamino) arylsulfonamide and optionally other additional pharmaceutical agents; pharmaceutical kit; treatment method; and its use for the treatment or prophylaxis of cancer.
CL2011003327A1 (en) Pharmaceutical composition comprising finafloxacin and an anti-inflammatory agent; use in the treatment of ophthalmic, otic or nasal infections.
CO6551744A2 (en) COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY
CO6700840A2 (en) Theobromine in combination with an expectorant or mucolytic for use in therapy
CO6551745A2 (en) COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY
CL2009000665A1 (en) Pyrrolidinyl derived compounds; pharmaceutical composition comprising said compounds; and its use in the treatment of anxiety, depression or both.
CL2012003265A1 (en) Tamarind seed polysaccharide for use in the treatment of infectious diseases; pharmaceutical and / or anti-inflammatory dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide.
PA8806501A1 (en) TRIAZOLOTRIAZINAS AND TRIAZOLOPIRAZINAS AND ITS USE
AR070456A1 (en) COMBINATION INCLUDING PACLITAXEL FOR THE TREATMENT OF CANCER OF OVARY AND ITS USE
ECSP12012132A (en) COMBINATION OF THEOBROMINE WITH A DESCONGESTIVE AND ITS USE FOR THE TOS TREATMENT
ECSP10010661A (en) DRONEDARONE FOR THE PREVENTION OF CARDIOVERSION
CL2010001594A1 (en) Use of nifurtimox to prepare a medicine useful in the treatment of diseases caused by trichomonadide.
UY33662A (en) COMBINATIONS THAT INCLUDE DHODH INHIBITORS AND COX INHIBITORS
CL2011003248A1 (en) Pharmaceutical composition comprising crf and an angiogenesis inhibitor; Useful for the prevention and treatment of cancer.